TBIO: Telesis Bio, Inc. Stock

by  •  • Comments Off on TBIO: Telesis Bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 11.44
Enterprise Value ($M) 26.68
Book Value ($M) 29.54
Book Value / Share 0.98
Price / Book 0.39
NCAV ($M) -21.54
NCAV / Share -0.72
Price / NCAV -0.53

Profitability (mra)
Return on Invested Capital (ROIC) -0.75
Return on Assets (ROA) -0.54
Return on Equity (ROE) -1.02

Liquidity (mrq)
Quick Ratio 1.87
Current Ratio 2.36

Balance Sheet (mrq) ($M)
Current Assets 19.33
Assets 70.41
Liabilities 40.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 27.51
Operating Income -35.15
Net Income -47.72
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -34.67
Cash from Investing -5.74
Cash from Financing 11.56

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
07-05 13G/A BroadOak Fund IV, LLC 10.35
07-05 13G/A GATTACA Mining LLC 21.28 47.88
06-15 13D Novalis LifeSciences Investments II, L.P. 19.99
06-07 13D/A Northpond Ventures, LP 47.90 85.97
06-02 13D/A Northpond Ventures, LLC 33.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 25,376 140,383 18.08
2024-04-30 4,334 79,736 5.44
2024-04-29 13,047 25,552 51.06

(click for more detail)

Similar Companies
SYRE – Spyre Therapeutics, Inc. SYRS – Syros Pharmaceuticals, Inc.
TARS – Tarsus Pharmaceuticals, Inc. TECH – Bio-Techne Corporation
TERN – Terns Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io